Abstract:Cardiac channelopathies are a group of inherited syndromes that can cause malignant arrhythmias and sudden cardiac death, particularly in the pediatric population. Today, a 12-lead electrocardiogram is the most effective tool to diagnose these diseases. Incomplete penetrance and variable expressivity are hallmarks of these syndromes. Some of these malignant entities may remain hidden and only a trigger such as exercise, emotions or fever can unmask the electrical pattern to diagnose the disease. Sudden cardiac death may be the first manifestation of any of these syndromes. The use of complementary tests that allow early diagnosis is strongly recommended, among which we find: pharmacological provocations, exercise tests, and genetic analysis. Genetic testing makes it possible to unravel the origin of the disease, and also identify family members who carry the harmful genetic defect and are therefore at risk. One of the main challenges in this area is the large number of genetic variants of uncertain significance, which prevent effective translation into clinical practice. Early identification of the pediatric population at risk and adequate risk stratification are crucial to adopting personalized preventive measures that reduce the risk of lethal episodes in this population. What is Known: • In the pediatric population, malignant arrhythmias leading to sudden cardiac death are mainly caused by inherited syndromes. • A conclusive genetic diagnosis unravels the origin of the syndrome and allows cascade screening to identify relatives carrying the genetic alteration. What is New: • The use of sequencing technologies allows a broad genetic analysis, helping to unravel new genetic alterations causing inherited arrhythmogenic syndromes. • A periodic reanalysis of genetic variants that currently have an ambiguous role will help discern those that are truly pathogenic.

Genetics of cardiac arrhythmias and sudden cardiac death

Genetics of sudden death: focus on inherited channelopathies

Inherited arrhythmia syndromes: applying the molecular biology and genetic to the clinical management

Genetics of sudden cardiac death

Sudden cardiac death and genetic ion channelopathies: long QT, Brugada, short QT, catecholaminergic polymorphic ventricular tachycardia, and idiopathic ventricular fibrillation

Genetic and molecular basis of cardiac arrhythmias: impact on clinical management parts I and II

Modifier genes for sudden cardiac death

Inherited arrhythmogenic diseases: the complexity beyond monogenic disorders

Inherited conditions of arrhythmia: translating disease mechanisms to patient management

Cardiogenetics: the role of genetic testing for inherited arrhythmia syndromes and sudden death

The usual suspects in sudden cardiac death of the young: a focus on inherited arrhythmogenic diseases

Genetic defects of cardiac ion channels. The hidden substrate for torsades de pointes

Pathogenesis and Clinical Characteristics of Hereditary Arrhythmia Diseases

The Genetic Basis of Sudden Cardiac Death: From Diagnosis to Emerging Genetic Therapies

Ion Channel Disorders and Sudden Cardiac Death

Cardiac channelopathies in pediatrics: a genetic update

Role of genetic analyses in cardiology: part I: mendelian diseases: cardiac channelopathies

Incomplete Penetrance and Variable Expressivity: Hallmarks in Channelopathies Associated with Sudden Cardiac Death

Genetics of ion-channel disorders

Ryanodine receptor and calsequestrin in arrhythmogenesis: what we have learnt from genetic diseases and transgenic mice

Cardiac sodium channel diseases